In this disease-specific context, we argue that such missense variants affecting evolutionarily conserved residues within well-characterized functional domains can be regarded as likely pathogenic variants in patients with a single copy of SMN1. It is especially prudent to factor clinical data into the assessment in these cases, with cases presenting with SMA phenotypes providing additional evidence for disease association. This evidence concerns the gene SMN1 and proximal spinal muscular atrophy.